Eevia Health launches new brain health, sleep ingredient from tart cherry
The company introduced the new ingredient, Feno-Cerasus, at November’s SupplySide West trade show.
Photo © iStockphoto.com
Finland-based ingredient supplier Eevia Health Plc has launched a new brain and sleep health ingredient for dietary supplements and food that is a standardized extract of tart cherry (Prunus cerasus). The company, which was founded in March 2017, introduced the new ingredient, Feno-Cerasus, at November’s SupplySide West trade show in Las Vegas.
The company points to clinical studies showing that tart cherry has benefits not only for cognitive performance but also for sleep quality. “From PubMed in October 2022, one can also observe 39 clinical studies have been published in peer-reviewed journals,” the company’s press release states. “Tart cherries have been studied for muscle recovery (15 studies, 280 subjects), metabolic health (8 studies, 180 subjects), cardiovascular health (5 studies, 150 subjects), antioxidant properties in clinical studies (2 studies, 59 subjects), and positive results also in pain (2 studies, 108 subjects).”
The company says that Feno-Cerasus is rich in a natural spectrum of polyphenolic compounds and is standardized to 10% anthocyanins, including cyanidin-3-glucoside and cyanidin-3-rutinoside. The ingredient is also non-GMO, gluten-free, vegan, and offers a pleasing taste profile suited for applications like gummies, the firm says.
